Stay updated with breaking news from Zai Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Handelsbanken Fonder AB increased its stake in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 9.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,155 shares of the company’s stock after purchasing an additional 8,366 shares during […]
Frontline Zejula maintenance therapy decreased the risk of disease progression or death in patients with newly diagnosed ovarian cancer.
- Company to Host Conference Call and Webcast on August 8, 2023, at 8:00 a.m. ETSHANGHAI, China and CAMBRIDGE, Mass., July 20, 2023 -- Zai Lab Limited today announced that it will report financial...
The Phase 3 PRIME study demonstrates that treatment with ZEJULA significantly extends progression-free survival versus placebo and reduces the risk of disease progression or death by 55% ...
Zai Lab Ltd. (ZLAB) shares are progressing more than 5 percent on Tuesday morning trade. Yesterday, the company had reported positive data from ADHERE study of VYVGART Hytrulo in patients with chronic inflammatory demyelinating polyneuropathy.